Clinical Trial Update: A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating TAK-781 in healthy volunteers and in participants with non-cirrhotic primary sclerosing cholangitis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• TAK-781 (TAK-781)

Snippet

Sponsor: Takeda | Conditions: Healthy Volunteers, Primary Sclerosing Cholangitis | Phase 1 | Status: RECRUITING